Scholay

学术搜索 · AI 审稿 · LaTeX 协作

Benedito A. Carneiro

机构：Brown University, Oklahoma State University Oklahoma City, Lifespan · ORCID：0000-0002-5468-1126

发表论文 540 篇 · 总被引 9731 次 · h-index 40

代表论文

  • 16 ABBV-CLS-484: A Novel Oral PTPN2/1 Inhibitor for Cancer Immunotherapy (2026 · The Oncologist)
  • Safety and Efficacy of Intratumoral MEDI1191, an IL12 mRNA Lipid Nanoparticle, plus Intravenous Durvalumab in Patients with Advanced Solid Tumors: A First-in-Human Study (2026 · Clinical Cancer Research)
  • Figure 1 from Camonsertib, an ATRi, in Combination with Low-Dose Gemcitabine in Solid Tumors with DNA Damage Response Aberrations: Preclinical and Phase Ib Results (2026)
  • Supplementary Table S1 from Camonsertib, an ATRi, in Combination with Low-Dose Gemcitabine in Solid Tumors with DNA Damage Response Aberrations: Preclinical and Phase Ib Results (2026)
  • Supplementary Table S3 from Camonsertib, an ATRi, in Combination with Low-Dose Gemcitabine in Solid Tumors with DNA Damage Response Aberrations: Preclinical and Phase Ib Results (2026)
  • Figure 2 from Camonsertib, an ATRi, in Combination with Low-Dose Gemcitabine in Solid Tumors with DNA Damage Response Aberrations: Preclinical and Phase Ib Results (2026)